Petra Hoogendoorn

Navigating Medical Device Certification: A Qualitative Exploration of Barriers and Enablers Amongst Innovators, Notified Bodies and Other Stakeholders

Rebecca Baines, Petra Hoogendoorn, Sebastian Stevens et al. · Therapeutic Innovation & Regulatory Science · 2022 · 28 citations · Full text

Phase II Trial of 13-cis-Retinoic Acid Plus Interferon   in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group

Andrew Arnold, Jean-Pierre Ayoub, Louise Douglas et al. · JNCI Journal of the National Cancer Institute · 1994 · 24 citations

Andrew Arnold, Phase Ii Trial, Non-small-cell Lung Cancer +15

What Makes a Quality Health App—Developing a Global Research-Based Health App Quality Assessment Framework for CEN-ISO/TS 82304-2: Delphi Study

Petra Hoogendoorn, Anke Versluis, Sanne van Kampen et al. · JMIR Formative Research · 2022 · 23 citations · Full text

Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee

Enrico G. Caiani, Hareld Kemps, Petra Hoogendoorn et al. · European Heart Journal - Digital Health · 2024 · 17 citations · Full text

Patient and caregiver return to work after a primary brain tumor

Emma Nicklin, Isaac Phang, Susan Short et al. · Neuro-Oncology Practice · 2023 · 11 citations · Full text